The journal retracts the article titled “Tioconazole and Chloroquine Act Synergistically to Combat Doxorubicin-Induced Toxicity via Inactivation of PI3K/AKT/mTOR Signaling Mediated ROS-Dependent Apoptosis and Autophagic Flux Inhibition in MCF-7 Breast Cancer Cells.” [1], cited above.
Following the article’s publication, concerns were brought to the attention of the Editorial Office regarding the reliability of the figures presented in this article [1].
Adhering to our complaints procedure, the investigation was conducted by the Editorial Office and Editorial Board. During this process, the authors were unable to satisfactorily explain the similarities between Figure 4(I-A) and Supplementary Figure S5(C II), nor could they provide the raw materials for the Editorial Board evaluation. As a result, the Editorial Board has lost confidence in the reliability of the findings and decided to retract this publication [1], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30, accessed on 6 January 2025).
This retraction was approved by the Editor-in-Chief of Pharmaceuticals.
The authors disagree with this decision.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.El-Gowily A.H., Loutfy S.A., Ali E.M.M., Mohamed T.M., Mansour M.A. RETRACTED: Tioconazole and Chloroquine Act Synergistically to Combat Doxorubicin-Induced Toxicity via Inactivation of PI3K/AKT/mTOR Signaling Mediated ROS-Dependent Apoptosis and Autophagic Flux Inhibition in MCF-7 Breast Cancer Cells. Pharmaceuticals. 2021;14:254. doi: 10.3390/ph14030254. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]